SOC Telemed Reports Fourth Quarter and Full-Year 2020 Results

Go back to SOC Telemed Reports Fourth Quarter and Full-Year 2020 Results

Telemed, Inc. (TLMD) Misses Q4 EPS by $1.77, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus

March 30, 2021 4:19 PM EDT

Telemed, Inc. (NASDAQ: TLMD) reported Q4 EPS of ($1.87), $1.77 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.87 million.

Fourth Quarter HighlightsFinancial performance for the three months ended December 31, 2020 compared to the three months ended December 31, 2019.

Completed transaction with Healthcare Merger Corp. and commenced public trading on Nasdaq.Bookings of $3.9 million compared to $2.0 million, a 95% increase primarily driven by the increased interest in telemedicine and overall momentum in the business.Revenue was $14.5 million compared to $16.6 million, a 13% decrease... More